Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes

Citation
J. Honnorat et al., Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes, EUR J NEURO, 11(12), 1999, pp. 4226-4232
Citations number
36
Categorie Soggetti
Neurosciences & Behavoir
Journal title
EUROPEAN JOURNAL OF NEUROSCIENCE
ISSN journal
0953816X → ACNP
Volume
11
Issue
12
Year of publication
1999
Pages
4226 - 4232
Database
ISI
SICI code
0953-816X(199912)11:12<4226:UPARBA>2.0.ZU;2-8
Abstract
Anti-CV2 autoantibodies have recently been discovered in patients with para neoplastic neurological diseases (PND). These disorders are associated with neuronal degeneration, mediated by autoimmune processes, in patients with systemic cancer. Anti-CV2 autoantibodies recognize a brain protein of 66 kD a developmentally regulated and specifically expressed by a subpopulation o f oligodendrocytes in the adult brain. Here, we demonstrate that anti-CV2 s era recognize several post-translationally modified forms of Ulip4/CRMP3, a member of a protein family related to the axonal guidance and homologous t o the Unc-33 gene product in Caenorhabditis elegans. The sequence of the hu man Ulip4/CRMP3 was determined and the gene localized to chromosome 10q25.2 -q26, a region mutated in glioblastomas and containing tumour suppressor ge nes. The identification of the Ulip/CRMP proteins as recognized by anti-CV2 sera should provide new insights into the role of Ulip/CRMPs in oligodendr ocytes and into pathophysiology of PND.